← Eichor
Study identifier: NCT05753748 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Condition: Barretts Esophagus With Dysplasia · Barrett Esophagus · Esophageal Adenocarcinoma  ·  Sponsor: University of Colorado, Denver

PhaseNA
Planned participants680
Who can joinAll sexes, 18 Years to 89 Years
Healthy volunteersNo

About this study

The purpose of this study is to learn the best approach to treating patients with known or suspected Barrett's esophagus by comparing endoscopic surveillance to endoscopic eradication therapy. To diagnose and manage Barrett's esophagus and low-grade dysplasia, doctors commonly use procedures called endoscopic surveillance and endoscopic eradication therapy. Endoscopic surveillance is a type of procedure where a physician will run a tube with a light and a camera on the end of it down the patients throat and remove a small piece of tissue. The piece of tissue, called a biopsy, is about the size of the tip of a ball-point pen and is checked for abnormal cells and cancer cells. Endoscopic eradication therapy is a kind of surgery which is performed to destroy the precancerous cells at the bottom of the esophagus, so that healthy cells can grow in their place. It involves procedures to either remove precancerous tissue or burn it. These procedures can have side effects, so it is not certain whether risking those side effects is worth the benefit people get from the treatments. While both of these procedures are widely accepted approaches to managing the condition, there is not enough research to show if one is better than the other. Barrett's esophagus and low-grade dysplasia does not always worsen to high-grade dysplasia and/or cancer. In fact, it usually does not. So, if a patient's dysplasia is not worsening, doctors would rather not put patients at risk unnecessarily. On t…

This description comes directly from the study's public registry record.

Talk to the study team

Jillian Welker  ·  2489127809  ·  jwelker89@gmail.com

Sandra Boimbo  ·  303-724-8892  ·  sandra.boimbo@cuanschutz.edu

Always discuss trial participation with your own doctor first.

Locations (23)

University of California, Los AngelesLos Angeles, California, United StatesRecruiting
Kaiser Permanente Oakland Medical CenterOakland, California, United StatesRecruiting
Kaiser PermanenteSan Jose, California, United StatesRecruiting
University of ColoradoAurora, Colorado, United StatesRecruiting
Florida Digestive Health SpecialistsSarasota, Florida, United StatesRecruiting
Northwestern Memorial HospitalChicago, Illinois, United StatesRecruiting
Indiana University Melvin & Bren Simon Cancer CenterIndianapolis, Indiana, United StatesRecruiting
Johns Hopkins UniverstiyBaltimore, Maryland, United StatesRecruiting
Beth Israel Deaconess Medical CenterBoston, Massachusetts, United StatesRecruiting
University of MichiganAnn Arbor, Michigan, United StatesRecruiting
Washington University in St. LouisSt Louis, Missouri, United StatesRecruiting
Dartmouth-Hitchcock Medical CenterLebanon, New Hampshire, United StatesRecruiting

+ 11 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05753748